510(k) Report

510(k) · Cleared

Cleared

MolecuLightDX

K211901510(k) SpecialCleared Jul 21, 202130-day reviewClass II21 CFR 878.4550

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

MolecuLight, Inc. · QJF Autofluorescence Imaging Adjunct Tool For Wounds

Cleared on Jul 21, 2021 as substantially equivalent to K191371 (MolecuLight, Inc., 2019) after a 30-day review. Its family tree reaches back 2 generations to 2018. 1 later device descends from it.

Decided
Jul 21, 2021
Review
30 days
Class
Class II
Product code
QJF
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to DEN170092 (2018). 1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2025: 1 descendant clearedDEN170092 · Fluobeam 800 Clinic Imaging Device used with Fluocase 800 Control System · Fluoptics · 2018K191371 · MolecuLight i:X · MolecuLight, Inc. · 2019201620182020202220242026
Descendants, by generation 1 generation forward: 1 descendant K191371 · MolecuLight i:X · MolecuLight, Inc. · 2019DEN170092 · Fluobeam 800 Clinic Imaging Device used with Fluocase 800 Control System · Fluoptics · 20180
  1. Root · 2 generations backDEN170092 Fluobeam 800 Clinic Imaging Device used with Fluocase 800 Control…Fluoptics · 2018
  2. 1 generation backK191371 MolecuLight i:XMolecuLight, Inc. · 2019
  3. This deviceK211901 MolecuLightDXMolecuLight, Inc. · 2021
  4. Descendant · cites it directly · 0 of its ownK242669 SnapshotGLO (KB100)Kent Imaging, Inc. · 2025 · Recalled

Most influential descendants

Showing 1 of 1 · See all
  • K242669SnapshotGLO (KB100)Kent Imaging, Inc. · 2025 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2DEN170092Fluobeam 800 Clinic Imaging Device used with Fluocase 800 Control SystemFluoptics2018—
−1K191371MolecuLight i:XMolecuLight, Inc.2019—
0 (this device)K211901MolecuLightDXMolecuLight, Inc.2021—
+1K242669SnapshotGLO (KB100)Kent Imaging, Inc.20251

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202510
FIG. 1 — Lineage of K211901, 2018–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QJF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QJF device

  1. #1 K251678 Swift Ray 1score 11.2 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K191371MolecuLight i:X
Summary page 4
…tofluorescence detection device, 21 CFR 878.4550, Class II, QJF Tape, Camera, Surgical, 21 CFR 878.4160, Class I, FXN Predicate Devices MolecuLight i:X K191371 Indications for Use The MolecuLightDX is a handheld imaging tool that allows clinicians diagnosing and treating skin wounds, at…
MolecuLight, Inc.2019—

Also cleared against K191371: 3 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K242669SnapshotGLO (KB100)Kent Imaging, Inc.20250

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 3 years and passes through 2 companies; a new generation was cleared every 1.6 years on median.
  • None of the 2 ancestors has a recall.
  • Of its descendants, K242669 (Kent Imaging, Inc., 2025) has gone furthest, with 0 descendants of its own.
  • 3 other devices also cite its predicate K191371.

How does its category compare?

All QJF devices

QJF Autofluorescence Imaging Adjunct Tool For Wounds: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.

FDA decisions per year · QJF

1in 2025

2019: 12021: 22022: 12023: 12025: 12026 (partial year): 1
2007high 2 (2021) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QJF

Too few QJF 510(k)s in any year since 2007 to give a median.

Recalls per year · QJF

1so far in 2026, the most since 2007

2026 (partial year): 1
2007high 1 (2026) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · QJF

No MAUDE report names QJF since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20191—00
20200—00
20212—00
20221—00
20231—00
20240—00
20251—00
20261—1—

What is it indicated for?

The MolecuLightDX is a handheld imaging tool that allows clinicians diagnosing and treating skin wounds, at the point of care, to (i) View and digitally record images of a wound, (ii) Measure and digitally record the size of a wound, and (iii) View and digitally record images of fluorescence emitted from a wound when exposed to an excitation light. The fluorescence image, when used in combination with clinical signs and symptoms, has been shown to…

Read the full statement (125 words)

The MolecuLightDX is a handheld imaging tool that allows clinicians diagnosing and treating skin wounds, at the point of care, to

(i) View and digitally record images of a wound,

(ii) Measure and digitally record the size of a wound, and

(iii) View and digitally record images of fluorescence emitted from a wound when exposed to an excitation light.

The fluorescence image, when used in combination with clinical signs and symptoms, has been shown to increase the likelihood that clinicians can identify wounds containing bacterial loads >104 CFU per gram as compared to examination of clinical signs and symptoms alone. The MolecuLightDX device should not be used to rule-out the presence of bacteria in a wound.

The MolecuLightDX does not diagnose or treat skin wounds.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K211901: MolecuLightDX.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K211901

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026